Author(s): Janusz Bartnicki, Irena Choroszy-Król
The incidence of Chlamydia trachomatis infection in pregnant women is estimated as 1-3 %. Clinical manifestations of infection in pregnants are diversified. The incidence of premature rupture of membranes (PROM), chorioamnionitis, and premature onset of labor coupled with decreased birth weight were all reported to be enhenced by Chlamydia trachomatis. In cases with cervical localization of Chlamydia trachomatis, a foetus infection during labor leads to neonatal conjunctivitis, atypical pneumonia, otitis media or nose-and-throat infection. Therefore, Chlamydia trachomatis screening need to be run at the first, routine medical examination in pregnancy, and the treatment should be implemented immediately after the pathogen identification. Oral medication with Erythromycin (4 x 500 mg / 7 days), or Amoxicillin (3 x 500 mg / 7-10 days) are standard treatments. The therapy is, however, not indicated in women below 14th week of pregnancy. A patient’s partner treatment is compulsory. In cases of Chlamydia trachomatis infection in parturients, a neonatologist should be mandatory informed about a threat, to put a neonate into a vigilant observation.